Kilcawley Construction have recently been awarded the sub structure contract for a new biologics unit at Alexion Pharmaceutical Facility in Athlone. The planned €100m investment in a new biologics unit will be an expansion of Alexion’s current operation in the town. Alexion is a global biopharmaceutical company developing therapies for patients with devastating and rare disorders including paroxysmal nocturnal haemoglobinuria (PNH) and atypical haemolytic uremic syndrome (aHUS).
Alexion AAMF Biologics Manufacturing Facility
